๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention?

โœ Scribed by Huseyin Bozbas; Aylin Yildirir; Serdar Mermer; Didem Konas; Ilyas Atar; Alp Aydinalp; Bulent Ozin; Mehmet E. Korkmaz; Haldun Muderrisoglu


Book ID
105633283
Publisher
Springer Healthcare Communications
Year
2007
Tongue
English
Weight
296 KB
Volume
24
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Differential release of cardiac enzymes
โœ Mark A. Matthews; Susan J. Kunselman; Joseph A. Gascho; Ian C. Gilchrist ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 2 views

## Abstract We hypothesized that using calcium channel blockers (CCBs) that dilate microvasculature during percutaneous coronary intervention (PCI) would result in lower postprocedural creatine phosphokinase (CPK). PCI can be complicated by elevated CPK that has been associated with impaired microv